# Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

> **NCT01005277** · — · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 2000 (estimated)

## Conditions studied

- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1
- Adult Acute Promyelocytic Leukemia With PML-RARA
- Childhood Acute Lymphoblastic Leukemia in Remission
- Childhood Acute Myeloid Leukemia
- Childhood Acute Myeloid Leukemia in Remission
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia

## Interventions

- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT01005277
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04-17
- **Primary completion:** 2016-05-05
- **Final completion:** —
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2022-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01005277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01005277, "Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01005277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*